BACKGROUND: Clinical subtypes of mild cognitive impairment (MCI) may represent different underlying aetiologies. METHODS: This European, multicentre, memory clinic based study (DESCRIPA) of non-demented subjects investigated whether MCI subtypes have different brain correlates on MRI and whether the relation between subtypes and brain pathology is modified by age. Using visual rating scales, medial temporal lobe atrophy (MTA) (0-4) and white matter hyperintensities (WMH) (0-30) were assessed. RESULTS: Severity of MTA differed between MCI subtypes (p<0.001), increasing from a mean of 0.8 (SD 0.7) in subjective complaints (n = 77) to 1.3 (0.8) in non-amnestic MCI (n = 93), and from 1.4 (0.9) in single domain amnestic MCI (n = 70) to 1.7 (0.9) in multiple domain amnestic MCI (n = 89). The association between MCI subtype and MTA was modified by age and mainly present in subjects >70 years of age. Severity of WMH did not differ between MCI subtypes (p = 0.21). However, the combination of MTA and WMH differed between MCI subtypes (p = 0.02) CONCLUSION: We conclude that MCI subtypes may have different brain substrates, especially in older subjects. Isolated MTA was mainly associated with amnestic MCI subtypes, suggesting AD as the underlying cause. In non-amnestic MCI, the relatively higher prevalence of MTA in combination with WMH may suggest a different pathophysiological origin.
BACKGROUND: Clinical subtypes of mild cognitive impairment (MCI) may represent different underlying aetiologies. METHODS: This European, multicentre, memory clinic based study (DESCRIPA) of non-demented subjects investigated whether MCI subtypes have different brain correlates on MRI and whether the relation between subtypes and brain pathology is modified by age. Using visual rating scales, medial temporal lobe atrophy (MTA) (0-4) and white matter hyperintensities (WMH) (0-30) were assessed. RESULTS: Severity of MTA differed between MCI subtypes (p<0.001), increasing from a mean of 0.8 (SD 0.7) in subjective complaints (n = 77) to 1.3 (0.8) in non-amnestic MCI (n = 93), and from 1.4 (0.9) in single domain amnestic MCI (n = 70) to 1.7 (0.9) in multiple domain amnestic MCI (n = 89). The association between MCI subtype and MTA was modified by age and mainly present in subjects >70 years of age. Severity of WMH did not differ between MCI subtypes (p = 0.21). However, the combination of MTA and WMH differed between MCI subtypes (p = 0.02) CONCLUSION: We conclude that MCI subtypes may have different brain substrates, especially in older subjects. Isolated MTA was mainly associated with amnestic MCI subtypes, suggesting AD as the underlying cause. In non-amnestic MCI, the relatively higher prevalence of MTA in combination with WMH may suggest a different pathophysiological origin.
Authors: Lynn Ossher; Ellen Bialystok; Fergus I M Craik; Kelly J Murphy; Angela K Troyer Journal: J Gerontol B Psychol Sci Soc Sci Date: 2012-03-27 Impact factor: 4.077
Authors: Ineke A van Rossum; Stephanie J B Vos; Leah Burns; Dirk L Knol; Philip Scheltens; Hilkka Soininen; Lars-Olof Wahlund; Harald Hampel; Magda Tsolaki; Lennart Minthon; Gilbert L'italien; Wiesje M van der Flier; Charlotte E Teunissen; Kaj Blennow; Frederik Barkhof; Daniel Rueckert; Robin Wolz; Frans Verhey; Pieter Jelle Visser Journal: Neurology Date: 2012-09-26 Impact factor: 9.910
Authors: Olof Lindberg; Mark Walterfang; Jeffrey C L Looi; Nikolai Malykhin; Per Ostberg; Bram Zandbelt; Martin Styner; Beatriz Paniagua; Dennis Velakoulis; Eva Orndahl; Lars-Olof Wahlund Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Emily R Lindemer; David H Salat; Eric E Smith; Khoa Nguyen; Bruce Fischl; Douglas N Greve Journal: Neurobiol Aging Date: 2015-05-28 Impact factor: 4.673
Authors: Marianne M Flak; Haakon R Hol; Susanne S Hernes; Linda Chang; Thomas Ernst; Andreas Engvig; Knut Jørgen Bjuland; Bengt-Ove Madsen; Elisabeth M S Lindland; Anne-Brita Knapskog; Ingun D Ulstein; Trine E E Lona; Jon Skranes; Gro C C Løhaugen Journal: Front Aging Neurosci Date: 2018-11-21 Impact factor: 5.750